Orig3n IPO

orig3n.com

Orig3n is a developer of DNA tests designed to help people understand the links between their genes and how their minds and bodies work, and researcher of cellular science to develop personalized therapies for repairing tissue damage and disease.

Founded2014
Total Funding to Date$85.64MM
Register for Details

For more details on financing and valuation for Orig3n, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Orig3n Ticker Symbol

Orig3n does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Orig3n Stock Price

The stock price for Orig3n will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Other companies like Orig3n in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM